Skip to content
10-Q

Quarterly Report

CONSTELLATION PHARMACEUTICALS INC

0001564590-20-048495

← back to feed
Filed
Oct 29, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2020 · Oct 23, 2020 47.58M sh
Capex Q3 2020 · Sep 30, 2020 $807K
Capex Q3 2020 · Sep 30, 2019 $683K
Operating Cash Flow Q3 2020 · Sep 30, 2020 −$77.87M
Operating Cash Flow Q3 2020 · Sep 30, 2019 −$55.29M
Long Term Debt Q3 2020 · Sep 30, 2020 $24.09M
Long Term Debt Q3 2020 · Dec 31, 2019 $29.64M
Short Term Debt Q3 2020 · Sep 30, 2020 $5.67M
Cash And Equivalents Q3 2020 · Sep 30, 2020 $117M
Cash And Equivalents Q3 2020 · Dec 31, 2019 $334.33M
Stockholders Equity Q3 2020 · Sep 30, 2020 $442.77M
Stockholders Equity Q3 2020 · Jun 30, 2020 $471.98M
Stockholders Equity Q3 2020 · Mar 31, 2020 $315.53M
Stockholders Equity Q3 2020 · Dec 31, 2019 $337.58M
Stockholders Equity Q3 2020 · Sep 30, 2019 $48.15M
Stockholders Equity Q3 2020 · Jun 30, 2019 $67.18M
Stockholders Equity Q3 2020 · Mar 31, 2019 $86.08M
Stockholders Equity Q3 2020 · Dec 31, 2018 $104.16M
Current Liabilities Q3 2020 · Sep 30, 2020 $31.27M
Current Liabilities Q3 2020 · Dec 31, 2019 $22.76M
Total Liabilities Q3 2020 · Sep 30, 2020 $62.68M
Total Liabilities Q3 2020 · Dec 31, 2019 $61.55M
Current Assets Q3 2020 · Sep 30, 2020 $494.47M
Current Assets Q3 2020 · Dec 31, 2019 $386.99M
Total Assets Q3 2020 · Sep 30, 2020 $505.45M
Total Assets Q3 2020 · Dec 31, 2019 $399.13M
Sga Expense Q3 2020 · Sep 30, 2020 $7.94M
Sga Expense Q3 2020 · Sep 30, 2020 $20.8M
Sga Expense Q3 2020 · Sep 30, 2019 $4.81M
Sga Expense Q3 2020 · Sep 30, 2019 $14.13M
Rd Expense Q3 2020 · Sep 30, 2020 $25.44M
Rd Expense Q3 2020 · Sep 30, 2020 $68.15M
Rd Expense Q3 2020 · Sep 30, 2019 $16.24M
Rd Expense Q3 2020 · Sep 30, 2019 $47.87M
Net Income Q3 2020 · Sep 30, 2020 −$33.78M
Net Income Q3 2020 · Sep 30, 2020 −$88.97M
Net Income Q3 2020 · Jun 30, 2020 −$29.75M
Net Income Q3 2020 · Mar 31, 2020 −$25.44M
Net Income Q3 2020 · Dec 31, 2019 −$85.6M
Net Income Q3 2020 · Sep 30, 2019 −$21.15M
Net Income Q3 2020 · Sep 30, 2019 −$61.34M
Net Income Q3 2020 · Jun 30, 2019 −$20.77M
Net Income Q3 2020 · Mar 31, 2019 −$19.43M
Operating Income Q3 2020 · Sep 30, 2020 −$33.38M
Operating Income Q3 2020 · Sep 30, 2020 −$88.95M
Operating Income Q3 2020 · Sep 30, 2019 −$21.05M
Operating Income Q3 2020 · Sep 30, 2019 −$62M